The consensus price target hints at a 144.7% upside potential for Coya Therapeutics, Inc. (COYA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...

Tenpoint Therapeutics, Ltd. ("Tenpoint"), a global, clinical-stage biotechnology company focused on developing groundbreaking ...

Many were forced to postpone cancer screenings for several months in 2020 as Covid-19 overwhelmed doctors and hospitals, but ...

Shares of Aclaris Therapeutics were trading higher after the company said regulators had cleared its new drug application for a trial of ATI-052, its potential treatment for immuno-inflammatory ...

Join STAT on May 19 to explore advancements in cancer care with expert guest speakers. Learn how health care pros can ...